Clinical Trials Directory

Trials / Conditions / Narcolepsy Type 2

Narcolepsy Type 2

10 registered clinical trials studyying Narcolepsy Type 2 — 6 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingA Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
NCT07502443
Alkermes, Inc.Phase 3
RecruitingEpidemiology of Narcolepsy Type 1 and Type 2 in Spain
NCT07299097
Takeda—
RecruitingA Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
NCT07096674
Centessa Pharmaceuticals (UK) LimitedPhase 2
RecruitingA Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)
NCT06952699
TakedaPhase 2
RecruitingA Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
NCT06767683
Alkermes, Inc.Phase 2 / Phase 3
RecruitingA Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
NCT06752668
Centessa Pharmaceuticals (UK) LimitedPhase 2
CompletedA Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 2
NCT06555783
Alkermes, Inc.Phase 2
CompletedImproving Social Relationships for Adolescents With Central Disorders of Hypersomnolence
NCT06251063
Boston Children's HospitalN/A
CompletedNarcolepsy Nightmare Study
NCT05709873
Northwestern UniversityN/A
CompletedA Study of TAK-861 in Participants With Narcolepsy Type 2
NCT05687916
TakedaPhase 2